Table 2.
Clinical characteristics of rejection and non-rejection groups
| Variables | Rejection (n = 26) | Non-rejection (n = 238) | P-value | |
|---|---|---|---|---|
| Age (SD, yr) | 48.81 (9.84) | 51.55 (9.96) | 0.18 | |
| Gender | Male | 19 | 177 | 1.00 |
| Female | 7 | 61 | ||
| The time from LT date (mo) | 26.34 ± 33.72 | 24.11 ± 35.19 | 0.75 | |
| Pre-transplant MELD score | 22.46 ± 11.15 | 20.64 ± 11.18 | 0.43 | |
| Pre-transplant Child score | 9.54 ± 2.73 | 9.38 ± 2.78 | 0.78 | |
| Bilirubin (μmol/L) | 33.46 ± 29.55 | 17.03 ± 14.21 | <0.01 | |
| AST (IU/L) | 69.42 ± 50.16 | 27.55 ± 16.56 | <0.01 | |
| ALT (IU/L) | 65.15 ± 52.73 | 24.39 ± 18.75 | <0.01 | |
| Lymphocyte (×109/L) | 0.98 ± 0.84 | 1.40 ± 0.83 | 0.015 | |
| Tarcrolimus | 6.84 ± 2.68 | 6.13 ± 2.31 | 0.14 | |
| Total ischemia (min) | 182 ± 123 | 207 ± 106 | 0.26 | |
| CD8T proportion (%) | 16.64 ± 10.85 | 23.39 ± 11.33 | <0.01 | |